Shared genetic risk factors and causal association between psoriasis and coronary artery disease.
Matthew T PatrickQinmengge LiRachael WasikowskiNehal MehtaJohann E GudjonssonJames T ElderXiang ZhouLam C TsoiPublished in: Nature communications (2022)
Psoriasis and coronary artery disease (CAD) are related comorbidities that are well established, but whether a genetic basis underlies this is not well studied. We apply trans-disease meta-analysis to 11,024 psoriasis and 60,801 CAD cases, along with their associated controls, identifying one opposing and three shared genetic loci, which are confirmed through colocalization analysis. Combining results from Bayesian credible interval analysis with independent information from genomic, epigenomic, and spatial chromatin organization, we prioritize genes (including IFIH1 and IL23A) that have implications for common molecular mechanisms involved in psoriasis and CAD inflammatory signaling. Chronic systemic inflammation has been associated with CAD and myocardial infarction, and Mendelian randomization analysis finds that CAD as an exposure can have a significant causal effect on psoriasis (OR = 1.11; p = 3×10 -6 ) following adjustment for BMI and waist-hip ratio. Together, these findings suggest that systemic inflammation which causes CAD can increase the risk of psoriasis.
Keyphrases
- coronary artery disease
- genome wide
- percutaneous coronary intervention
- cardiovascular events
- systematic review
- coronary artery bypass grafting
- risk factors
- body mass index
- atopic dermatitis
- heart failure
- healthcare
- transcription factor
- gene expression
- dna damage
- cardiovascular disease
- meta analyses
- aortic valve
- atrial fibrillation